Medication info
Irbesartan 150 mg Tablet

Irbesartan 150 mg Tablet

Prescription medicationOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
White or almost white, oval-shaped, biconvex tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200800335 · Notified 2008.01.08 · Insurance code 642704080

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes

  • Essential hypertension
  • hypertension
  • kidney disease in patients with Type 2 diabetes
View approved original text

This medication is used to effectively manage high blood pressure. It is especially suitable for patients with essential hypertension and can also help prevent kidney disease in patients with Type 2 diabetes as part of a hypertension treatment regimen. Therefore, both blood pressure control and kidney function protection can be expected.

How to take

Adult dose

1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant and nursing mothers should not take this medication. Patients with severe liver impairment or allergies to this medication should also avoid use. This drug contains lactose and is not suitable for patients with lactose intolerance or related genetic disorders. Diabetic patients with poor kidney function should not take this medication in combination with certain drugs. Elderly patients or patients with compromised liver function, heart disease, or kidney disease should use this medication with caution. This medication has blood pressure-lowering effects, which may cause symptoms of hypotension or dizziness, so caution is advised. Kidney function and serum potassium levels should be monitored through regular blood tests, as hyperkalemia may occur. Caution should be taken when taking it with other antihypertensive medications, diuretics, or potassium supplements due to potential interactions. Dizziness or fatigue may occur while driving or operating machinery, so caution is necessary. In cases of overdose, hypotension or arrhythmias may manifest, and immediate consultation with medical personnel is required. It is advisable to avoid use in children as safety and efficacy have not been established. If unusual symptoms occur during use, notify medical personnel immediately, especially if symptoms of angioedema such as swelling of the face, lips, or tongue appear, in which case use should be discontinued immediately.

Side effects

  • Respiratory infections
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal trauma
Show 96 more
  • chest pain
  • dyspepsia
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infections
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • heart murmur
  • myocardial infarction
  • angina pectoris
  • arrhythmia
  • conduction abnormality
  • cardiac arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • hives
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle stiffness
  • arthritis
  • myalgia
  • joint rigidity
  • bursitis
  • muscle weakness
  • sleep disturbances
  • paralysis
  • hypersomnia
  • mood disorders
  • depression
  • sensory disturbances
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory disturbances
  • otitis
  • earache
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • hyperkalemia
  • hypersensitivity reaction
  • rash
  • hives
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • dyspepsia
  • tinnitus
  • elevated plasma creatine kinase
  • arthralgia
  • hepatitis
  • abnormal liver function
  • renal failure
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally in a cool, dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, oval-shaped, biconvex tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.